HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven M Callister Selected Research

OspC protein

4/2013Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease.
6/2005Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
7/2003C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven M Callister Research Topics

Disease

18Lyme Disease (Disease, Lyme)
10/2021 - 07/2002
16Infections
05/2020 - 07/2002
10Arthritis (Polyarthritis)
10/2021 - 01/2003
3Erythema
10/2021 - 04/2013
1Paralysis (Palsy)
10/2021
1Tick-Borne Diseases (Tick-Borne Disease)
11/2019
1Melanoma (Melanoma, Malignant)
12/2013
1Rheumatoid Arthritis
04/2013
1Hemolysis
07/2010
1Edema (Dropsy)
07/2008
1Hypertrophy
02/2006
1Hyperplasia
02/2006
1Osteoarthritis
01/2003

Drug/Important Bio-Agent (IBA)

12AntibodiesIBA
10/2021 - 07/2002
81-oleoyl-2-stearoylphosphatidylcholineIBA
07/2015 - 07/2003
6Immunoglobulin G (IgG)IBA
05/2020 - 07/2003
6Interferon-gamma (Interferon, gamma)IBA
01/2016 - 01/2003
5Peptides (Polypeptides)IBA
10/2021 - 06/2008
5Immunoglobulin M (IgM)IBA
05/2020 - 07/2003
5VaccinesIBA
01/2012 - 09/2002
5Interleukin-17 (Interleukin 17)IBA
07/2011 - 06/2003
4AntigensIBA
10/2021 - 06/2008
4ImmunosorbentsIBA
10/2021 - 06/2008
4EnzymesIBA
10/2021 - 06/2008
3Bacterial VaccinesIBA
05/2020 - 02/2009
3EpitopesIBA
04/2013 - 06/2005
3OspC proteinIBA
04/2013 - 07/2003
3CytokinesIBA
08/2008 - 01/2003
3Amino AcidsFDA Link
06/2008 - 06/2005
1InterferonsIBA
10/2021
1Carrier Proteins (Binding Protein)IBA
05/2020
1DecorinIBA
05/2020
1Immune Sera (Antisera)IBA
05/2020
14,5-dibromo-2-pyrrolic acidIBA
05/2020
1tributyl phosphate (TBP)IBA
11/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2013
1Tigecycline (Tygacil)FDA Link
09/2013
1Bacterial Proteins (Bacterial Protein)IBA
04/2013
1ReaginsIBA
04/2013
1Virulence Factors (Pathogenicity Factors)IBA
07/2010
1Lyme Disease VaccinesIBA
05/2009
1Interleukin-23 (Interleukin 23)IBA
08/2008
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2008
1Interleukin-6 (Interleukin 6)IBA
07/2008
1Transforming Growth Factor beta (TGF-beta)IBA
07/2008
1OspA proteinIBA
07/2008
1Interleukin-15 Receptors (Interleukin 15 Receptor)IBA
02/2006
1Interleukin-15 (Interleukin 15)IBA
02/2006
1Proteins (Proteins, Gene)FDA Link
11/2004
1Complement System Proteins (Complement)IBA
11/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2003

Therapy/Procedure

2Therapeutics
10/2021 - 01/2016
1Aftercare (After-Treatment)
10/2021
1Condoms (Condom)
10/2004